IO BIOTECH INC's ticker is and the CUSIP is 449778109. A total of 20 filers reported holding IO BIOTECH INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,908,369 | +59.3% | 1,353,453 | +120.9% | 0.09% | +91.5% |
| Q2 2023 | $1,197,854 | +25.8% | 612,713 | +20.7% | 0.05% | +11.9% |
| Q1 2023 | $951,825 | -18.5% | 507,640 | 0.0% | 0.04% | 0.0% |
| Q4 2022 | $1,167,572 | -80.0% | 507,640 | -76.5% | 0.04% | -80.2% |
| Q3 2022 | $5,851,000 | -42.0% | 2,159,155 | 0.0% | 0.21% | -44.9% |
| Q2 2022 | $10,083,000 | +51.6% | 2,159,155 | +58.5% | 0.38% | +54.6% |
| Q1 2022 | $6,649,000 | -14.1% | 1,362,144 | 0.0% | 0.25% | -5.7% |
| Q4 2021 | $7,744,000 | – | 1,362,144 | – | 0.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 1,120,437 | $5,938,000 | 1.50% |
| Vivo Capital, LLC | 3,015,545 | $15,982,000 | 1.10% |
| Novo Holdings A/S | 3,277,932 | $17,373,000 | 0.92% |
| Soleus Capital Management, L.P. | 672,734 | $3,565,000 | 0.46% |
| PFM Health Sciences, LP | 1,362,144 | $6,649,000 | 0.25% |
| RA Capital Management | 1,857,755 | $9,846,000 | 0.22% |
| Avoro Capital Advisors LLC | 2,055,883 | $9,580,000 | 0.18% |
| Ergoteles LLC | 11,126 | $59,000 | 0.00% |
| Capital World Investors | 1,235,000 | $6,546,000 | 0.00% |
| VANGUARD GROUP INC | 62,234 | $330,000 | 0.00% |